January 08 2018 | Contributed by Grau & Angulo.
On October 20 2017 Barcelona Commercial Court Number 4 lifted the preliminary injunctions that it had previously granted ex parte at the request of Gilead in relation to the imminent market launch of tenofovir and emtricitabine generic medicinal products by Mylan and Teva.
